Skip to main content

Animations

MJFF Publications

5671 - 5680 of 6557 Results
Title
Year
  • Year
  • 2022
  • 2021
  • 2021
  • 2020
  • 2020
  • 2021
  • 2021
  • 2021
  • 2020
  • 2022
  • Summary Details
    OPEN
    Title: Opicapone in Uk Clinical Practice: effectiveness, Safety and Cost Analysis in Patients With Parkinson’s Disease
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.2217/nmt-2021-0057
    Citation Count: 9
  • Summary Details
    OPEN
    Title: In Silico Studies Comparing the Adjuvant Therapies Approved for Parkinson’s disease
    Journal Name: Journal of Drug Delivery and Therapeutics
    Publisher: Society of Pharmaceutical Tecnocrats
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.22270/jddt.v11i3-s.4813
    Citation Count: 2
  • Summary Details
    OPEN
    Title: An efficient and scalable synthesis of thiazolo ring fused 2-pyridones using flow chemistry
    Journal Name: Arkivoc
    Publisher: ARKAT USA, Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.24820/ark.5550190.p011.445
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Clinical outcomes of globus pallidus deep brain stimulation for Parkinson disease: a comparison of intraoperative MRI– and MER-guided lead placement
    Journal Name: Journal of Neurosurgery
    Publisher: Journal of Neurosurgery Publishing Group (JNSPG)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3171/2019.12.jns192010
    Citation Count: 27
  • Summary Details
    OPEN
    Title: MR-guided focused ultrasound pallidotomy for Parkinson’s disease: safety and feasibility
    Journal Name: Journal of Neurosurgery
    Publisher: Journal of Neurosurgery Publishing Group (JNSPG)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3171/2020.6.jns192773
    Citation Count: 100
  • Summary Details
    OPEN
    Title: Development, Efficacy and Safety of Once-daily, Bedtime, Extended-release Amantadine (Gocovri®) to Treat Dyskinesia and OFF Time in Parkinson’s Disease
    Journal Name: Neurology
    Publisher: Touch Medical Media, Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.17925/usn.2021.17.1.36
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Am I My Cousin's Keeper? A Proposal to Protect Relatives of Genetic Database Subjects
    Journal Name: Indiana Health Law Review
    Publisher: IUPUI University Library
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.18060/25052
    Citation Count: 3
  • Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia
    2021
    Summary Details
    OPEN
    Title: Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia
    Journal Name: Current Alzheimer Research
    Publisher: Bentham Science Publishers Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2174/1567205018666210219105949
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammation
    Journal Name: Mucosal Immunology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41385-020-00354-7
    Citation Count: 40
  • Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease
    2022
    Summary Details
    OPEN
    Title: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605
    Citation Count: 24
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.